First Allied Advisory Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

First Allied Advisory Services’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,097	Closed	-$215K	–	1151
2020 Q1	$215K	Buy	1,097 +80	+8%	+$17.2K	0.01%	907
2019 Q4	$211K	Buy	+1,017	New	+$188K	0.01%	1100

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

First Allied Advisory Services's LKFT Position: Q2 2020 in Review

First Allied Advisory Services sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2020, closing a stake of 1,097 shares — an estimated $215K sold.

First Allied Advisory Services first reported a position in LKFT in Q4 2019 and held it in 2 quarters. The position peaked at $215K in Q1 2020. 143 funds tracked by Wall St. Rank hold LKFT as of Q2 2020.

First Allied Advisory Services reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2020 after selling out during the quarter.
First Allied Advisory Services sold 1,097 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2020, an estimated $215K.
First Allied Advisory Services first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 2 quarters.
First Allied Advisory Services's Lakefront Biotherapeutics American Depositary Shares position peaked at $215K in Q1 2020.
143 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2020.

Based on First Allied Advisory Services's 13F filing for Q2 2020, filed 13 Aug 2020.